Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. acquired a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 3,000 shares of the company's stock, valued at approximately $499,000.
A number of other institutional investors have also recently bought and sold shares of the company. Assetmark Inc. raised its holdings in Astera Labs by 374.1% during the third quarter. Assetmark Inc. now owns 128 shares of the company's stock valued at $25,000 after buying an additional 101 shares in the last quarter. Hilltop National Bank raised its holdings in Astera Labs by 100.0% during the fourth quarter. Hilltop National Bank now owns 200 shares of the company's stock valued at $33,000 after buying an additional 100 shares in the last quarter. Aventura Private Wealth LLC bought a new position in Astera Labs during the fourth quarter valued at about $33,000. Wexford Capital LP bought a new position in Astera Labs during the third quarter valued at about $39,000. Finally, National Bank of Canada FI raised its holdings in Astera Labs by 159.0% during the third quarter. National Bank of Canada FI now owns 202 shares of the company's stock valued at $39,000 after buying an additional 124 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company's stock.
Astera Labs Stock Performance
Astera Labs stock opened at $349.17 on Friday. The business's 50-day simple moving average is $186.48 and its 200-day simple moving average is $163.86. The firm has a market capitalization of $59.85 billion, a PE ratio of 235.93, a PEG ratio of 4.31 and a beta of 3.35. Astera Labs, Inc. has a 52 week low of $84.78 and a 52 week high of $354.53.
Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts' consensus estimates of $0.54 by $0.07. The business had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm's revenue for the quarter was up 93.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Research analysts forecast that Astera Labs, Inc. will post 1.84 earnings per share for the current year.
Analyst Upgrades and Downgrades
ALAB has been the topic of several recent research reports. TD Cowen raised their target price on Astera Labs from $140.00 to $225.00 and gave the company a "hold" rating in a report on Wednesday, May 6th. UBS Group initiated coverage on Astera Labs in a report on Tuesday, April 21st. They set a "neutral" rating and a $180.00 target price on the stock. Weiss Ratings upgraded Astera Labs from a "hold (c-)" rating to a "hold (c)" rating in a report on Thursday, May 21st. Loop Capital initiated coverage on Astera Labs in a report on Thursday, March 5th. They set a "buy" rating and a $250.00 target price on the stock. Finally, Stifel Nicolaus raised their target price on Astera Labs from $236.00 to $260.00 and gave the company a "buy" rating in a report on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $233.75.
Check Out Our Latest Stock Report on ALAB
Insider Transactions at Astera Labs
In other news, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total value of $19,692,630.00. Following the transaction, the director directly owned 319,863 shares in the company, valued at approximately $34,420,457.43. The trade was a 36.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 325,693 shares of Astera Labs stock in a transaction dated Friday, April 17th. The stock was sold at an average price of $172.14, for a total value of $56,064,793.02. Following the completion of the transaction, the chief executive officer owned 4,079,322 shares in the company, valued at $702,214,489.08. The trade was a 7.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 2,316,257 shares of company stock worth $474,860,636. Company insiders own 12.50% of the company's stock.
About Astera Labs
(
Free Report)
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.